BRPI0518394A2 - derivados de quinazolina de mtki - Google Patents
derivados de quinazolina de mtkiInfo
- Publication number
- BRPI0518394A2 BRPI0518394A2 BRPI0518394-4A BRPI0518394A BRPI0518394A2 BR PI0518394 A2 BRPI0518394 A2 BR PI0518394A2 BR PI0518394 A BRPI0518394 A BR PI0518394A BR PI0518394 A2 BRPI0518394 A2 BR PI0518394A2
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- hydrogen
- het
- alkyloxy
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/529—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63422804P | 2004-12-08 | 2004-12-08 | |
US60/634,228 | 2004-12-08 | ||
EP04106385.5 | 2004-12-08 | ||
EP04106383 | 2004-12-08 | ||
PCT/EP2005/056609 WO2006061417A2 (en) | 2004-12-08 | 2005-12-08 | Macrocyclic quinazole derivatives and their use as mtki |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0518394A2 true BRPI0518394A2 (pt) | 2008-11-18 |
BRPI0518394B1 BRPI0518394B1 (pt) | 2020-12-15 |
BRPI0518394B8 BRPI0518394B8 (pt) | 2021-05-25 |
Family
ID=34930015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0518394A BRPI0518394B8 (pt) | 2004-12-08 | 2005-12-08 | composto derivado de quinazolina de mtki, uso do mesmo, inibidor de cinase e composição farmacêutica |
Country Status (22)
Country | Link |
---|---|
US (1) | US20100152174A1 (pt) |
EP (1) | EP1828201B1 (pt) |
JP (1) | JP5140431B2 (pt) |
KR (1) | KR101320431B1 (pt) |
CN (2) | CN102532163B (pt) |
AR (1) | AR051985A1 (pt) |
AU (1) | AU2005313350B2 (pt) |
BR (1) | BRPI0518394B8 (pt) |
CA (1) | CA2588764C (pt) |
DK (1) | DK1828201T3 (pt) |
EA (1) | EA013995B1 (pt) |
ES (1) | ES2559305T3 (pt) |
HU (1) | HUE027253T2 (pt) |
JO (1) | JO3088B1 (pt) |
MX (1) | MX2007006820A (pt) |
MY (1) | MY148503A (pt) |
NZ (1) | NZ555496A (pt) |
PA (1) | PA8654501A1 (pt) |
SI (1) | SI1828201T1 (pt) |
TW (2) | TWI432440B (pt) |
UA (1) | UA91522C2 (pt) |
WO (1) | WO2006061417A2 (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PA8603801A1 (es) * | 2003-05-27 | 2004-12-16 | Janssen Pharmaceutica Nv | Derivados de la quinazolina |
UA83881C2 (en) | 2003-12-18 | 2008-08-26 | Янссен Фармацевтика Н.В. | Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
NI200700147A (es) | 2004-12-08 | 2019-05-10 | Janssen Pharmaceutica Nv | Derivados de quinazolina inhibidores de cinasas dirigidos a multip |
JP2009542778A (ja) * | 2006-07-13 | 2009-12-03 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Mtkiキナゾリン誘導体 |
EP2077845A2 (en) * | 2006-10-27 | 2009-07-15 | Janssen Pharmaceutica N.V. | Macrocyclic quinazoline derivatives as vegfr3 inhibitors |
KR20090086977A (ko) * | 2006-10-27 | 2009-08-14 | 얀센 파마슈티카 엔.브이. | 골암의 치료 또는 예방을 위한 mtki 1의 용도 |
DK2170827T3 (da) * | 2007-06-21 | 2013-11-18 | Janssen Pharmaceutica Nv | Indolin-2-oner og aza-indolin-2-oner |
DK2185562T3 (en) * | 2007-07-27 | 2016-02-22 | Janssen Pharmaceutica Nv | PYRROLOPYRIMIDINES SUITABLE FOR TREATING PROLIFERATIVE DISEASES |
RS53350B (en) | 2008-09-22 | 2014-10-31 | Array Biopharma, Inc. | SUBSTITUTED COMPOUNDS OF IMIDASO [1,2-B] PYRIDASINE AS INK KINASE INHIBITORS |
TWI577680B (zh) | 2008-10-22 | 2017-04-11 | 亞雷生物製藥股份有限公司 | 作為TRK激酶抑制劑之經取代吡唑并〔1,5-a〕嘧啶化合物 |
AR077468A1 (es) | 2009-07-09 | 2011-08-31 | Array Biopharma Inc | Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa |
ES2534335T3 (es) | 2010-05-20 | 2015-04-21 | Array Biopharma, Inc. | Compuestos macrocíclicos como inhibidores de la Trk cinasa |
DK3102200T3 (da) * | 2014-02-07 | 2023-05-22 | Exithera Pharmaceuticals Inc | Terapeutisk forbindelse og sammensætning |
MA39823A (fr) | 2014-04-03 | 2018-01-09 | Janssen Pharmaceutica Nv | Dérivés de pyridine macrocyclique |
MA39822A (fr) | 2014-04-03 | 2018-02-06 | Janssen Pharmaceutica Nv | Dérivés de pyrimidine bicycle |
FI3699181T3 (fi) | 2014-11-16 | 2023-03-28 | Array Biopharma Inc | Kiteinen muoto (s)-n-(5-((r)-2-(2,5-diluorifenyyli)-pyrrolidin-1-yyli)-pyratsolo[1,5-a]pyrimidin-3-yyli)-3-hydroksipyrrolidiini-1-karboksamidivetyysulfaatista |
MX2018005087A (es) | 2015-10-26 | 2019-05-16 | Loxo Oncology Inc | Mutaciones puntuales en cáncer resistente a trk y métodos relacionados con las mismas. |
US10045991B2 (en) | 2016-04-04 | 2018-08-14 | Loxo Oncology, Inc. | Methods of treating pediatric cancers |
JP7061602B2 (ja) | 2016-04-04 | 2022-04-28 | ロクソ オンコロジー, インコーポレイテッド | (S)-N-(5-((R)-2-(2,5-ジフルオロフェニル)-ピロリジン-1-イル)-ピラゾロ[1,5-a]ピリミジン-3-イル)-3-ヒドロキシピロリジン-1-カルボキサミドの液体製剤 |
DK3458456T3 (da) | 2016-05-18 | 2020-12-14 | Array Biopharma Inc | Fremstilling af (s)-n-(5-((r)-2-(2,5-difluorphenyl)pyrrolidin-1-yl)pyrazol[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidin-1-carboxamid |
JOP20190092A1 (ar) | 2016-10-26 | 2019-04-25 | Array Biopharma Inc | عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها |
JOP20190213A1 (ar) | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | مركبات حلقية ضخمة كمثبطات لكيناز ros1 |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2423536A1 (de) * | 1974-05-15 | 1975-11-27 | Bayer Ag | 3-amino-phenylessigsaeure-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als herbizide |
US4110333A (en) * | 1976-05-17 | 1978-08-29 | Janssen Pharmaceutica N.V. | 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds |
US4442278A (en) * | 1981-12-03 | 1984-04-10 | Hughes Aircraft Company | Ethynyl-substituted s-triazine derivatives, polymers thereof and process for making the same |
US5721237A (en) * | 1991-05-10 | 1998-02-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
RU2147304C1 (ru) * | 1993-12-07 | 2000-04-10 | Эли Лилли Энд Компани | Бис-индолмалеимидные макроциклические производные, способ их получения (варианты) и фармацевтическая композиция |
IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
US5654307A (en) * | 1994-01-25 | 1997-08-05 | Warner-Lambert Company | Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
AU3817595A (en) * | 1994-10-31 | 1996-05-23 | Dsm N.V. | Catalyst composition and process for the polymerization of an olefin |
GB9508538D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
EA199800372A1 (ru) * | 1995-11-14 | 1998-10-29 | Дзе Дюпон Мерк Фармасьютикал Компани | Новые макроциклические соединения-ингибиторы |
DE19608588A1 (de) * | 1996-03-06 | 1997-09-11 | Thomae Gmbh Dr K | Pyrimido [5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
EP0892789B2 (en) * | 1996-04-12 | 2009-11-18 | Warner-Lambert Company LLC | Irreversible inhibitors of tyrosine kinases |
GB9718972D0 (en) * | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
US6002008A (en) * | 1997-04-03 | 1999-12-14 | American Cyanamid Company | Substituted 3-cyano quinolines |
US6288082B1 (en) * | 1998-09-29 | 2001-09-11 | American Cyanamid Company | Substituted 3-cyanoquinolines |
ATE316527T1 (de) * | 1999-08-27 | 2006-02-15 | Boehringer Ingelheim Pharma | Substituierte indolinone als tyrosinkinase inhibitoren |
WO2001025220A1 (en) * | 1999-10-07 | 2001-04-12 | Amgen Inc. | Triazine kinase inhibitors |
US6864255B2 (en) * | 2001-04-11 | 2005-03-08 | Amgen Inc. | Substituted triazinyl amide derivatives and methods of use |
BR0210391A (pt) * | 2001-06-12 | 2004-06-15 | Elan Pharm Inc | Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto |
US7501516B2 (en) * | 2001-07-16 | 2009-03-10 | Astrazeneca Ab | Quinoline derivatives and their use as tyrosine kinase inhibitors |
US6924285B2 (en) * | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
EP1528925B1 (en) * | 2002-07-09 | 2009-04-22 | Astrazeneca AB | Quinazoline derivatives for use in the treatment of cancer |
DE10239042A1 (de) * | 2002-08-21 | 2004-03-04 | Schering Ag | Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel |
US20050021480A1 (en) * | 2003-05-16 | 2005-01-27 | Hyperspace Communications, Inc. | Method and apparatus for creating and validating an encrypted digital receipt for third-party electronic commerce transactions |
PA8603801A1 (es) * | 2003-05-27 | 2004-12-16 | Janssen Pharmaceutica Nv | Derivados de la quinazolina |
UA83881C2 (en) * | 2003-12-18 | 2008-08-26 | Янссен Фармацевтика Н.В. | Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
CN1893944B (zh) * | 2003-12-18 | 2011-07-06 | 詹森药业有限公司 | 具有抗增殖活性的3-氰基喹啉衍生物 |
MY169441A (en) * | 2004-12-08 | 2019-04-11 | Janssen Pharmaceutica Nv | 2,4, (4,6) pyrimidine derivatives |
UA92608C2 (en) * | 2005-06-30 | 2010-11-25 | Янссен Фармацевтика Н.В. | Cyclic anilino - pyridinotriazines as gsk-3 inhibitors |
ATE469158T1 (de) * | 2005-11-16 | 2010-06-15 | S | Heteroalkylgebundene pyrimidinderivate |
JP2009542778A (ja) * | 2006-07-13 | 2009-12-03 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Mtkiキナゾリン誘導体 |
DK2170827T3 (da) * | 2007-06-21 | 2013-11-18 | Janssen Pharmaceutica Nv | Indolin-2-oner og aza-indolin-2-oner |
DK2185562T3 (en) * | 2007-07-27 | 2016-02-22 | Janssen Pharmaceutica Nv | PYRROLOPYRIMIDINES SUITABLE FOR TREATING PROLIFERATIVE DISEASES |
JP5480824B2 (ja) * | 2008-03-10 | 2014-04-23 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Plkキナーゼ阻害剤としての4−アリール−2−アニリノ−ピリミジン |
-
2005
- 2005-11-28 JO JOP/2005/0188A patent/JO3088B1/ar active
- 2005-12-05 PA PA20058654501A patent/PA8654501A1/es unknown
- 2005-12-06 MY MYPI20055704A patent/MY148503A/en unknown
- 2005-12-07 TW TW094143060A patent/TWI432440B/zh active
- 2005-12-07 AR ARP050105124A patent/AR051985A1/es not_active Application Discontinuation
- 2005-12-07 TW TW102141302A patent/TWI511970B/zh active
- 2005-12-08 EP EP05826362.5A patent/EP1828201B1/en active Active
- 2005-12-08 EA EA200701233A patent/EA013995B1/ru not_active IP Right Cessation
- 2005-12-08 SI SI200532035T patent/SI1828201T1/sl unknown
- 2005-12-08 MX MX2007006820A patent/MX2007006820A/es active IP Right Grant
- 2005-12-08 US US11/720,693 patent/US20100152174A1/en not_active Abandoned
- 2005-12-08 UA UAA200705396A patent/UA91522C2/ru unknown
- 2005-12-08 CN CN201110392750.4A patent/CN102532163B/zh active Active
- 2005-12-08 DK DK05826362.5T patent/DK1828201T3/en active
- 2005-12-08 ES ES05826362.5T patent/ES2559305T3/es active Active
- 2005-12-08 WO PCT/EP2005/056609 patent/WO2006061417A2/en active Application Filing
- 2005-12-08 NZ NZ555496A patent/NZ555496A/en unknown
- 2005-12-08 KR KR1020077013133A patent/KR101320431B1/ko active IP Right Grant
- 2005-12-08 CA CA2588764A patent/CA2588764C/en active Active
- 2005-12-08 CN CN2005800420435A patent/CN101072781B/zh active Active
- 2005-12-08 JP JP2007544918A patent/JP5140431B2/ja active Active
- 2005-12-08 HU HUE05826362A patent/HUE027253T2/en unknown
- 2005-12-08 BR BRPI0518394A patent/BRPI0518394B8/pt active IP Right Grant
- 2005-12-08 AU AU2005313350A patent/AU2005313350B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0518394A2 (pt) | derivados de quinazolina de mtki | |
EA201171062A1 (ru) | Алкиламидные соединения и их применение | |
RS53167B (en) | 1-HETEROCYCLYL-1,5-DIHYDRO-PYRAZOLO [3,4-D] PYRIMIDIN-4-ONE DERIVATIVES AND THEIR APPLICATIONS AS A PDE9A MODULATOR | |
NO20065615L (no) | Adamantyl-pyrrolidin-2-onderivater som 11-beta-hydroksysteroiddehydrogenaseinhibitorer | |
AR064279A1 (es) | Compuestos basados en la 4-fenil-6-(2,2,2-trifluoro-1- feniletoxi) pirimidina y metodos de uso de los mismos | |
RS51660B (en) | 1`, 3`-DISUPSTITUATED-4-PHENYL-3,4,5,6-TETRAHYDRO-2H, 1`H- [1,4`] BIPYRIDINYL-2`-ONE | |
MX2011007455A (es) | Derivados oxadiazol como agonistas de los receptores de esfingosina-1-fosfato 1 (s1p1). | |
RS51674B (en) | PIPERIDIN-4-IL-PIRIDAZIN-3-ILAMINE DERIVATIVES AS A FAST DISSOCATING DOPAMIN 2 RECEIVER ANTAGONISTS | |
ME01421B (me) | 5-supstituisani derivati kinazolinona kao protivtumorska sredstva | |
BRPI0518424B8 (pt) | derivados de 2,4 (4,6) pirimidina, composição farmacêutica que os compreende, intermediários e uso dos mesmos | |
AR072016A1 (es) | Derivados de isoxazol que funcionan como potenciadores de los receptores de glutamato | |
RS53038B (en) | OXADIAZOLA DERIVATIVE Activate Sphingosine-1-Phosphate (SIP) | |
TW200612958A (en) | Substituted imidazole derivatives | |
ES2567311T3 (es) | 6-(3-Aza-biciclo[3.1.0]hex-3-il)-2-fenil-pirimidinas como antagonistas del receptor de ADP | |
RS54825B1 (sr) | Derivati azola | |
UA92730C2 (ru) | Аналоги бензазола и их применение | |
TW200732338A (en) | Aromatic compound | |
AR078461A1 (es) | Inhibidores macrociclicos de la replicacion de virus de la hepatitis c | |
CO6321266A2 (es) | Inhibidores limk2 compuestos de los cuales estan hechos y metodologia de uso | |
PL1831152T3 (pl) | Pochodne tetraliny i indanu oraz ich zastosowanie jako antagonistów 5-HT | |
UA96947C2 (ru) | Производные циннамоил-пиперазина и их применение как антагонистов par-1 | |
PH12020500292A1 (en) | Pyridine compound substituted with azole | |
TW200643002A (en) | Novel compound and liquid-crystal composition | |
RS53183B (en) | IMIDASOL DERIVATIVES AS GLUTAMATE RECEPTOR ANTAGONISTS | |
HUP0401949A2 (hu) | 4-Imidazolin-2-on-származékok |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/12/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/12/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |